Kimi Iguchi
Director of Finance/CFO at SAGE THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/03/2024
Profile
Currently, Kimi E. Iguchi occupies the position of Chief Financial Officer & Treasurer at SAGE Therapeutics, Inc. Ms. Iguchi is also on the board of Disarm Therapeutics, Inc. She previously was Vice President-Finance of Cyberkinetics Neurotechnology Systems, Inc., Chief Operating Officer-North America Region at Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting at Biogen, Inc. and Finance Manager at Biogen MA, Inc. (a subsidiary of Biogen, Inc.), Senior Director-Finance, Reporting & Analysis at Millennium Pharmaceuticals, Inc. and Manager-Business Assurance at PricewaterhouseCoopers LLP. Ms. Iguchi received an undergraduate degree from Drew University and an MBA from Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.14% | 12/02/2024 | 81,679 ( 0.14% ) | 2 M $ | 30/03/2024 |
Kimi Iguchi active positions
| Companies | Position | Start |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Director of Finance/CFO | 28/02/2013 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 24/10/2018 |
Former positions of Kimi Iguchi
| Companies | Position | End |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 31/08/2011 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Director of Finance/CFO | 30/05/2007 |
| BIOGEN INC. | Corporate Officer/Principal | 31/12/1997 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 31/12/1994 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Training of Kimi Iguchi
| Drew University | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| Private companies | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Kimi Iguchi
